IRTC - アイリズム・テクノロジ―ズ （iRhythm Technologies Inc.） アイリズム・テクノロジ―ズIRTCのチャート
IRTCの企業情報
| symbol | IRTC |
|---|---|
| 会社名 | iRhythm Technologies Inc （アイリズム・テクノロジ―ズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 アイリズム・テクノロジーズ(iRhythm Technologies Inc.)は米国のデジタルヘルス会社である。同社はバイオセンサー技術、患者データ、分析及び医療専門知識を統合するソリューションの開発・商業化に従事する。同社は主力ソリューションとZIOサービスを提供する。そのZIOサービスはZIO XTパッチ、アルゴリズム及びZIOレポートを含む。同社のmyZIOは、患者がZIOパッチを身に着けている間に起こたまたは持続した症状を入力するための方法を患者に提供する。同社のZIOイベントカードは失神、動悸及び息と眩暈の息切れ等の一過性症状が発生する患者のために使用される。同社のZIO XTパッチは高い患者コンプライアンス及び高い診断率を促進する非侵襲性且つ耐水性心臓モニターである。同社のアルゴリズムは捕獲された心拍データの量を分析する。その分析レポートは患者の医師に提供される。同社のZIOレポートは高い診断率を生成し、患者管理を変更する。 アイリズム・テクノロジ―ズは米国の医療機器メ―カ―。ウエアラブル端末であるバイオセンサ―を利用し、心臓の不整脈をクラウド・ベ―スの分析で臨床的に診断する。デジタル・ヘルスケア事業を展開し、同社開発の「ZIO」パッチは14日間装着が可能で、鼓動をデ―タ分析する。本社はカリフォルニア州サンフランシスコ。 iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients. |
| 本社所在地 | 650 Townsend Street Suite 500 San Francisco CA 94103 USA |
| 代表者氏名 | Abhijit Y. Talwalkar Abhijit Y. Talwalkar |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 415-632-5700 |
| 設立年月日 | 38961 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2016年 |
| 従業員数 | 575人 |
| url | www.iRhythmTech.com |
| nasdaq_url | https://www.nasdaq.com/symbol/irtc |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -36.77800 |
| 終値（lastsale） | 83.17 |
| 時価総額（marketcap） | 1991812214.62 |
| 時価総額 | 時価総額（百万ドル） 1912.781 |
| 売上高 | 売上高（百万ドル） 119.25100 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1859.439 |
| 当期純利益 | 当期純利益（百万ドル） -40.99600 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Irhythm Technologies Inc revenues increased 46% to $66M. Net loss increased 99% to $23.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative - B increase of 64% to $55.8M (expense) Research and development - Balancing val increase of 56% to $7.2M (expense). |
IRTCのテクニカル分析
IRTCのニュース
Is Now An Ideal Time To Purchase iRhythm Technologies Inc. (NASDAQ: IRTC) Stock? 2022/11/02 18:00:00 Stocks Register
iRhythm Technologies Inc. (NASDAQ:IRTC) traded at $118.44 at last check on Wednesday, November 02, made a downward move of -6.57% on its previous day’s price. Looking at the stock we see that its previous close was $126.77 and the beta (5Y monthly) reads 1.33 with the day’s price range being $126.74 – $131.51. In terms … Is Now An Ideal Time To Purchase iRhythm Technologies Inc. (NASDAQ: IRTC) Stock? Read More »
You Should Read This Analysis Before Investing in iRhythm Technologies Inc. (NASDAQ:IRTC) 2022/11/02 17:32:00 US Post News
iRhythm Technologies Inc. (IRTC)’s stock has witnessed a price declined of -5.96% from the previous close with its current price standing at $119.21. Its current price is -29.69% under its 52-week high of $169.54 and 65.57% more than its 52-week low of $72.00. Based on the past 30-day period, the stock price is -12.99% below […]
iRhythm Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023 2022/11/02 12:30:00 Wallstreet:Online
SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today commented on the recent announcement from the Centers for Medicare and Medicaid Services (“CMS”) that it has issued the Medicare Physician Fee Schedule (MPFS) Final Rule for Calendar
iRhythm Posts Smaller Than Expected Loss In Q3, But Shares Fall On Lowered Annual Guidance 2022/11/02 10:28:01 Benzinga
iRhythm Technologies Inc (NASDAQ: IRTC ) posted an adjusted EPS loss of $(0.63) , better than $(0.81) a year ago and the consensus of $(0.83). The wearable heart monitor developer recorded sales growth of 21.6% to $103.87 million. "Despite the ongoing staffing and capacity challenges, we grew registration volumes by more than 20% in the third … Full story available on Benzinga.com
iRhythm Technologies, Inc. (IRTC) Q3 2022 Earnings Call Transcript 2022/11/02 03:07:08 Seeking Alpha
iRhythm Technologies, Inc. (NASDAQ:NASDAQ:IRTC) Q3 2022 Earnings Conference Call November 01, 2022 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations…
iRhythm: Fairly Priced At Current Multiples (NASDAQ:IRTC) 2022/09/02 14:48:45 Seeking Alpha
iRhythm Technologies continues to offer long-term value for seasoned healthcare investors who can hedge around portfolio variance. Click to read our analysis.
iRhythm Technologies (IRTC) Investor Presentation - Slideshow 2022/08/17 17:24:15 Seeking Alpha
The following slide deck was published by iRhythm Technologies, Inc.
iRhythm Technologies, Inc. (IRTC) CEO Quentin Blackford on Q2 2022 Results - Earnings Call Transcript 2022/08/06 23:32:04 Seeking Alpha
iRhythm Technologies, Inc. (NASDAQ:NASDAQ:IRTC) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations…
iRhythm Technologies, Inc. Common Stock (IRTC) Q2 2022 Earnings Call Transcript 2022/08/06 09:00:54 The Motley Fool
IRTC earnings call for the period ending June 30, 2022.
iRhythm Technologies PT Raised to $185 at Truist Securities 2022/08/05 10:14:04 Investing.com
https://www.investing.com/news/pro/irhythm-technologies-pt-raised-to-185-at-truist-securities-432SI-2864842
iRhythm Technologies, Inc. (IRTC) CEO Quentin Blackford on Q2 2022 Results - Earnings Call Transcript 2022/08/06 23:32:04 Seeking Alpha
iRhythm Technologies, Inc. (NASDAQ:NASDAQ:IRTC) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations…
iRhythm Technologies, Inc. Common Stock (IRTC) Q2 2022 Earnings Call Transcript 2022/08/06 09:00:54 The Motley Fool
IRTC earnings call for the period ending June 30, 2022.
iRhythm Technologies PT Raised to $185 at Truist Securities 2022/08/05 10:14:04 Investing.com
https://www.investing.com/news/pro/irhythm-technologies-pt-raised-to-185-at-truist-securities-432SI-2864842
iRhythm Technologies PT Raised to $178 at BTIG 2022/08/05 10:01:07 Investing.com
https://www.investing.com/news/pro/irhythm-technologies-pt-raised-to-178-at-btig-432SI-2864810
iRhythm Technologies: Q2 Earnings Insights 2022/08/04 21:40:38 Benzinga
iRhythm Technologies (NASDAQ: IRTC ) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings iRhythm Technologies beat estimated earnings by 14.13%, reporting an EPS of $-0.79 versus an … Full story available on Benzinga.com